Press Releases

KIRKLAND, Wash., Feb. 3, 2020 /PRNewswire/ -- Verity Solutions earned Category Leader for 340B Management Systems for the third year in a row in the

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 3, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced topline results from the phase 2/3 DISTINCT clinical study evaluating Unituxin® (dinutuximab) Injection added to irinotecan compared to irinotecan or topotecan al

NEW YORK, Feb. 3, 2020 /PRNewswire/ -- Graham-Pelton announced today the appointment of Walt Edwards as Senior Advisor to support its rapidly growing portfolio of national and international healthcare institutions. In this capacity, Edwards will help shape the vision, strategy, and philanthropic engagement opportunities of Graham

NASHVILLE, Tenn., Feb. 3, 2020 /PRNewswire/ -- Experian Health, a leading provider of revenue cycle management products that include claims management

- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP)- Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published in The Lancet Oncology LONDON, Feb. 3, 2020 /PRNewswire/ -- GlaxoSmithKline plc tod

IRVINE, Calif., Feb. 04, 2020 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2019. Revenues for the quarter ended December 31, 2019 were $148 million, an increase of 1.4% from revenues of $146 million in the same quarter of the prior year.  Earnings per share for the quarter ended December 31,

TUTTLINGEN, Germany and ZURICH, Feb. 3, 2020 /PRNewswire/ -- KARL STORZ, the leading endoscopy manufacturer, and VirtaMed, world leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.The long-term collaboration between KARL STORZ and VirtaMed in th

NORCROSS, Ga., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc.(NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company’s President and CEO, will present at the 3rd Global NASH Congress 2020 at the London Heathrow Marriott on Tuesday, February 11, at 3:00 p.m. (15:00

Due to overwhelming demand, the submission of abstracts for the 44th World Hospital Congress of the International Hospital Federation has been extended until 14 February. The IHF World Hospital Congress is a unique global forum that brings together leaders of hospitals, health services, and healthcare organizations to discuss key drivers of national and international policy, management, financial trends and solutions. Through this forum multidisciplinary exchange of knowledge, exper

DOVER, Ohio, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Fine Arts Skin & Laser is now offering EMsculpt®, a device that uses high-intensity focused electromagnetic energy to non-surgically firm and tone the abdomen, buttocks, and arms—for a look comparable to the result of months of dedicated workouts. Available at the